Restoration of Peripheral Intermediate and Classical Monocytes Expressing HLA-DR in Patients With Lung Adenocarcinoma After Platinum-Based Chemotherapy

Lung adenocarcinoma represents one of the lung cancer subtypes with major prevalence. Accumulating evidence indicates that the immune system plays an important role in the evolution of the neoplastic process; additionally, several reports suggest that chemotherapy has an immunomodulatory effect. In...

Full description

Saved in:
Bibliographic Details
Published in:Technology in cancer research & treatment 2018-01, Vol.17, p.1533033818764720-1533033818764720
Main Authors: Rivas-Fuentes, Selma, Iglesias, Anjarath Higuera, Trejo, Ana García, Castro, Daniel Yair Chavarría, Figueroa, Norma Inclán, Pérez, Teresa Aguirre, Saldaña, Renata Báez, Rosete, Patricia Gorocica
Format: Article
Language:English
Subjects:
Adenocarcinoma of Lung - drug therapy
Adenocarcinoma of Lung - immunology
Adenocarcinoma of Lung - mortality
Adult
Aged
Antineoplastic Agents - therapeutic use
Chemotherapy
Cytokines
Female
HLA-DR Antigens - immunology
Humans
Kaplan-Meier Estimate
Leukocytes, Mononuclear - drug effects
Leukocytes, Mononuclear - immunology
Lung cancer
Lung Neoplasms - drug therapy
Lung Neoplasms - immunology
Lung Neoplasms - mortality
Male
Middle Aged
Original
Platinum Compounds - therapeutic use
Prognosis
T-Lymphocyte Subsets - drug effects
T-Lymphocyte Subsets - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lung adenocarcinoma represents one of the lung cancer subtypes with major prevalence. Accumulating evidence indicates that the immune system plays an important role in the evolution of the neoplastic process; additionally, several reports suggest that chemotherapy has an immunomodulatory effect. In order to identify the peripheral subpopulations of leukocytes that may change after chemotherapy, we evaluated several peripheral immune subpopulations of monocytes and lymphocytes by multicolor flow cytometry. In addition, we also measured cytokines and growth factors on plasma in order to evaluate the pro-inflammatory context in patients with lung adenocarcinoma after chemotherapy. We found that HLA-DR+ classical and intermediate monocytes were decreased in patients before chemotherapy, compared to controls. After chemotherapy, the relative percentage of those subpopulations was restored. In addition, interleukin 1β, interleukin 12, and interleukin 5 were increased after chemotherapy compared to prechemotherapy levels, while MIP-1β was decreased.
ISSN:1533-0346
1533-0338
DOI:10.1177/1533033818764720